OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
57
Results
Show all
Save search
Copy query
Show results for
Unknown
(52)
Proteomics
(5)
Organisms
Andropogon gerardi
(3)
Bacteria
(3)
Canis lupus familiaris
(3)
Cnidaria
(3)
Ensifer adhaerens
(3)
Fasciola
(3)
Human alphaherpesvirus 1 strain 17
(3)
Human alphaherpesvirus 1 strain KOS
(3)
Human betaherpesvirus 5
(3)
Human herpesvirus 2 strain 186
(3)
Madurella mycetomatis
(3)
Mesocricetus auratus
(3)
Miscanthus x giganteus
(3)
Mus musculus
(3)
Panicum virgatum
(3)
Platyhelminthes
(3)
Pseudomonas aeruginosa AES-1R
(3)
Pseudomonas aeruginosa PA103
(3)
Rattus norvegicus
(3)
Rattus rattus
(3)
Rhodococcus jostii RHA1
(3)
Rhodopseudomonas palustris
(3)
Saccharomyces cerevisiae
(3)
Shigella
(3)
Sorghastrum nutans
(3)
Streptococcus dysgalactiae subsp. equisimilis SK1249
(3)
Streptococcus pneumoniae
(3)
Streptomyces coelicolor A3(2)
(3)
Tripsacum dactyloides
(3)
Homo sapiens
(1)
Repository
pride
(3)
iProX
(1)
MassIVE
(1)
Disease
Acute leukemia
(1)
Technology Type
Mass Spectrometry
(3)
Bottom-up proteomics
(1)
Data-dependent acquisition
(1)
HDMSE
(1)
Shotgun proteomics
(1)
Instrument Platform
LTQ Orbitrap Elite
(1)
Publication Date
2025
(1)
2026
(1)
2023
(1)
2022
(1)
Release Date
2019
(8)
2025
(7)
2022
(7)
2023
(5)
2018
(4)
2017
(3)
2013
(3)
2024
(2)
2021
(2)
2020
(2)
2015
(2)
2014
(2)
2011
(2)
2026
(1)
2012
(1)
2008
(1)
Lab affiliation
Department of Chemistry & Chemical Biology, Northeastern University
(1)
Department of Clinical and Molecular Medicine Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Trondheim, Norway
(1)
Imperial College London
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Potent Pyrimidine and Pyrrolopyrimidine Inhibitors of Testis-Specific Serine/Threonine Kinase 2 (TSSK2).
Not available
S-EPMC5962959
|
biostudies-literature
Cite
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors.
Not available
S-EPMC9611727
|
biostudies-literature
Cite
Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.
Not available
S-EPMC2603307
|
biostudies-literature
Cite
Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions.
Not available
S-EPMC3079198
|
biostudies-literature
Cite
Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors.
Not available
S-EPMC9467556
|
biostudies-literature
Cite
Pyrrolopyrimidine derivatives as dual COX-2/ACE2 inhibitors: design, synthesis, and anti-inflammatory evaluation.
Not available
S-EPMC12815825
|
biostudies-literature
Cite
The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors.
Not available
S-EPMC8711653
|
biostudies-literature
Cite
QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors.
Not available
S-EPMC10788635
|
biostudies-literature
Cite
Identification of a Biosynthetic Gene Cluster Responsible for the Production of a New Pyrrolopyrimidine Natural Product-Huimycin.
Not available
S-EPMC7439116
|
biostudies-literature
Cite
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.
Not available
S-EPMC6467197
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
